Drugmakers can't be sued on overcharge: U.S. Supreme Court

to disrupt the $30 billion Medicaid program for outpatient prescription drugs. Among the companies appealing were Pfizer Inc., Merck & Co. Inc., AstraZeneca, GlaxoSmithKline P.L.C., Bristol-Myers Squibb and Bayer A.G. The Obama administration supported...